Intellectual Property - December 21, 2020
InfiCure Bio secures US patent
InfiCure Bio has recently been granted a patent in the United States for its preclinical model. At the same time a study describing the basics of the model has been accepted for publication in online journal Scientific Reports. “We are delighted and anticipate that thanks to this attention we will strengthen our position in the […]
Intellectual Property - December 8, 2020
Spago Nanomedical receives extended patent protection in Europe
Spago Nanomedical has received notice from the European Patent Office (EPO) that it intends to grant the company’s patent application including a critical component of the SpagoPix candidate drug SN132D. The granted patent will extend protection of SpagoPix in Europe until at least 2038. The second largest market for MRI contrast agents The granted patent, […]
Intellectual Property - October 14, 2020
Follicum obtains US patent
Follicum has announced that the patent which previously received a Notice of Allowance from the US Patent and Trademark Office has now also been formally approved by the authority. The patent is called “Peptides for Treatment of Diabetes” and the patent will be valid until 2038. The patent covers peptides from the company’s two peptide […]
Intellectual Property - September 2, 2020
Ilya Pharma awarded US Utility Patent
Ilya Pharma has announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 10,696,974 to the company. The patent includes broad claims that cover a plasmid capable of expressing the protein CXCL12 in lactic acid bacteria, transformed lactic acid bacterial strains comprising the plasmid, and a number of products comprising […]
Intellectual Property - August 14, 2020
Nordic Nanovector announces EU patent granted
Nordic Nanovector has announced the grant of an EU patent covering the use of Alpha37 for the treatment of Chronic Lymphocytic Leukemia (CLL) and non-Hodgkin’s lymphoma (NHL). Alpha37 is an investigational radioimmunoconjugate developed by Nordic Nanovector in collaboration with Orano Med comprising a proprietary chimeric CD37-targeting antibody conjugated to the alpha-particle generating radionuclide lead-212. Alpha37 […]
Intellectual Property - July 1, 2020
Sigrid Therapeutics obtains US patent
Sigrid Therapeutics has been granted a US patent by the United States Patent and Trademark Office (USPTO) covering the use of the company’s mesoporous silica particles (MSP)-based device SiPore15 for lowering of body fat, prevention and treatment of obesity. “This granted patent further strengthens Sigrid’s global IP portfolio while significantly enlarging the commercial attractiveness of […]
